Phibro Animal Health Corporation Class A (PAHC)

Price$29.87

Value ScoreC

Growth ScoreB

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-40.48%

Price vs S&P 500 (4W)-48.88%

VGM Score50.20

Market Capitalization$1.25B

P/E Ratio (Annual)25.88x

Indicated Dividend Yield (Annual)1.56%

All Metrics

P/CF (Annual)15.59x

Book Value / Share (Quarterly)$8.92

P/TBV (Annual)4.15x

Indicated Dividend (Annual)$0.48

Revenue Growth (3Y)11.21%

Cash Flow / Share (Quarterly)$0.31

Payout Ratio (TTM)20.43%

Price vs S&P 500 (YTD)-28.52%

Gross Margin (TTM)32.83%

Net Profit Margin (TTM)6.35%

EPS (TTM)$2.33

10-Day Avg Trading Volume0.37M

EPS Excl Extra (TTM)$2.33

Revenue Growth (5Y)10.12%

EPS (Annual)$1.19

Dividend / Share (Annual)$0.48

ROI (Annual)4.81%

Gross Margin (Annual)31.59%

Net Profit Margin (5Y Avg)3.81%

Cash / Share (Quarterly)$1.91

P/E Basic Excl Extra (TTM)13.11x

Revenue Growth QoQ (YoY)10.27%

EPS Growth (5Y)7.42%

P/E Normalized (Annual)25.88x

ROA (Last FY)3.55%

Revenue Growth TTM (YoY)25.98%

EBITD / Share (TTM)$5.64

ROE (5Y Avg)14.19%

Operating Margin (TTM)12.00%

Cash Flow / Share (Annual)$1.03

P/B Ratio3.45x

P/B Ratio (Quarterly)6.20x

Net Income / Employee (Annual)$19,500

EV / Revenue (TTM)1.29x

Net Interest Coverage (TTM)2.60x

ROA (TTM)6.81%

EPS Growth QoQ (YoY)14.14%

EV / EBITDA (TTM)8.37x

EPS Incl Extra (Annual)$1.19

Current Ratio (Annual)2.76x

Quick Ratio (Quarterly)1.26x

3-Month Avg Trading Volume0.33M

52-Week Price Return24.86%

EV / Free Cash Flow (Annual)46.13x

P/E Incl Extra (TTM)13.11x

Revenue / Employee (TTM)$606,100

Tangible BV / Share (Quarterly)$8.14

P/S Ratio (Annual)0.96x

Asset Turnover (Annual)0.95x

52-Week High$60.08

Operating Margin (5Y Avg)7.69%

EPS Excl Extra (Annual)$1.19

CapEx CAGR (5Y)2.38%

Tangible BV CAGR (5Y)16.29%

26-Week Price Return-24.55%

Quick Ratio (Annual)1.25x

13-Week Price Return-43.71%

Total Debt / Equity (Annual)2.52x

Current Ratio (Quarterly)3.17x

Enterprise Value$1.93B

Revenue / Share Growth (5Y)10.03%

Asset Turnover (TTM)1.07x

Book Value / Share Growth (5Y)8.69%

Revenue / Employee (Annual)$523,700

Inventory Turnover (Annual)2.50x

Pretax Margin (Annual)5.25%

Cash / Share (Annual)$1.90

3-Month Return Std Dev70.86%

Gross Margin (5Y Avg)31.15%

Net Income / Employee (TTM)$38,500

EBITDA CAGR (5Y)8.98%

EBITDA Interim CAGR (5Y)15.30%

ROE (Last FY)16.89%

Net Interest Coverage (Annual)3.52x

EPS Basic Excl Extra (Annual)$1.19

P/FCF (TTM)72.30x

Receivables Turnover (TTM)7.16x

EV / Free Cash Flow (TTM)151.09x

Total Debt / Equity (Quarterly)2.03x

EPS Incl Extra (TTM)$2.33

Receivables Turnover (Annual)6.52x

ROI (TTM)9.03%

Dividend Growth Rate (5Y)0.02%

P/S Ratio (TTM)0.83x

Pretax Margin (5Y Avg)5.50%

Revenue / Share (Annual)$31.87

Tangible BV / Share (Annual)$6.15

Forward P/E9.29x

Free OCF CAGR (5Y)10.58%

Price vs S&P 500 (52W)-3.35%

P/E Ratio (TTM)13.11x

EPS Growth TTM (YoY)197.88%

Year-to-Date Return-17.59%

5-Day Price Return-7.43%

EPS Normalized (Annual)$1.19

ROA (5Y Avg)3.78%

Net Profit Margin (Annual)3.72%

Month-to-Date Return-42.10%

Cash Flow / Share (TTM)$1.36

EBITD / Share (Annual)$3.84

EPS Growth (3Y)-0.78%

Operating Margin (Annual)8.52%

LT Debt / Equity (Annual)2.46x

P/CF (TTM)18.89x

ROI (5Y Avg)5.03%

P/E Excl Extra (TTM)13.11x

LT Debt / Equity (Quarterly)1.97x

EPS Basic Excl Extra (TTM)$2.33

P/TBV (Quarterly)6.79x

Payout Ratio (Annual)40.30%

P/B Ratio (Annual)3.62x

Dividend / Share (TTM)$0.48

Inventory Turnover (TTM)2.04x

Pretax Margin (TTM)8.59%

Book Value / Share (Annual)$7.05

Price vs S&P 500 (13W)-53.46%

Net Margin Growth (5Y)-2.40%

Dividend Yield (TTM)1.56%

Beta0.46x

P/FCF (Annual)29.86x

Revenue / Share (TTM)$36.55

ROE (TTM)29.49%

52-Week Low$22.85

vGradeC

gGradeB

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q3 260.76est. 0.73

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

2.44

2.50

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
PAHCPhibro Animal Health Corporation Class A	C	B	D	$29.87
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
PFEPfizer Inc.	B	C	C	$25.63
ABTAbbott Laboratories	C	C	D	$87.78
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

Phibro Animal Health Corp provides diversified animal health and mineral nutrition products for food-producing animals including poultry, swine, beef cattle, dairy cattle, and aquaculture. The company manufactures and markets antibacterials, anticoccidials, vaccines, and specialty nutritional products through three segments: Animal Health (its primary revenue driver), Mineral Nutrition, and Performance Products. The company operates in the United States and international markets.